Rifaximin for inflammatory bowel disease.
Guslandi
Mario
M
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D012008:Recurrence; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin